Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Price to Cash Earnings (PCE)

    Back to All Ratios
AD     Remove this Ad

AARTI PHARMALABS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 18.8813.599.72--

What is the latest Price to Cash Earnings (PCE) ratio of AARTI PHARMALABS ?

The latest Price to Cash Earnings (PCE) ratio of AARTI PHARMALABS is 18.88 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202518.88
Mar202413.59
Mar20239.72
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of AARTI PHARMALABS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 18.88
38.93
Mar2024 13.59
39.81
Mar2023 9.72
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Price to Cash Earnings (PCE) ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹5,857.0 Cr 1.1% -10.7% -12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

1.1%

-10.7%

-12.9%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses